79 Infos zu Markus Blaess

1 Aktuelle Nachrichten

Markus Blaess 1 , Lars Kaiser 1, 2 , Oliver Sommerfeld 3 , René Csuk 4 , Hans-Peter Deigner 1, 5, 6. Affiliation. Institute of Precision Medicine, ...

7 Profile in Sozialen Netzwerken

Markus Blaess’ berufliches Profil anzeigen LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- und Führungskräften wie Markus Blaess dabei …

› markus-blaess-4736a31a9

Sehen Sie sich das Karriere-Profil von Markus Blaess (Deutschland) auf LinkedIn an. LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- und ...

› markus-blaess-7493a446

1 Hobbys & Interessen

Anne K. Ellis et al., Allergy, Asthma & Clinical Immunology, ; Erika Yue Lee et al., Allergy, Asthma & Clinical Immunology, ; Markus Blaess et al., Lipids in ...

2 Infos zur Ausbildung

... Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19. Authors. Markus Blaess · ORCID ID ...

Helga Weinschrott · Isabel Quint · Markus Blaess · ORCID ID · René Csuk · ORCID ID · Manfred Jung · ORCID ID · Matthias Kohl · ORCID ID ... › ...

6 Bücher zum Namen

COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks. Markus Blaess,; Lars Kaiser,; Martin Sauer, ...

1. Sept · Markus Blaess Visit ORCID profile. Hochschule Furtwangen - Campus Villingen-Schwenningen Share this profile Share with email Share with twitter Share with ...

... Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19 Markus Blaess, Lars Kaiser, Oliver Sommerfeld, Simone Rentschler, ...

... Cristina Zubiria-Barrera, Tilman E. Klassert, Maximilian J. Lautenbach, Markus Blaess, Ralf A. Claus, Hortense Slevogt and Rainer König P17, ...

13 Dokumente

Markus Blaess 1, Lars Kaiser 1,2, Martin Sauer 3,4,5, René Csuk 6 and Hans-Peter Deigner 1,5,7, * 1 Institute of Precision Medicine, Medical and Life Sciences Faculty, Furtwangen University, ,

— Maximilian J. Lautenbach 3, Markus Blaess 2, Ralf A. Claus 2, Hortense Slevogt 3 and. Rainer König 1, 2*

von S Rao · · Zitiert von: 1 — João Pedro Saraiva, Marcus Oswald, Antje Biering, Cora Assmann, Tilman Klassert, Markus Blaess, Kristin. Czakai, Ralf Claus, Jürgen Löffler, ...

von H Yamada · — Markus Blaess et al., Lipids in Health and Disease, Powered by · Targeting settings · Do not sell my personal information · Google Analytics settings.

5 Wissenschaftliche Publikationen

Markus Blaess, Ralf A. Claus, Hans-Peter Deigner. Pages : View PDF. Article preview. Sorry, this component is empty. select article Development of ...

Assmann,; Tilman Klassert,; Markus Blaess,; Kristin Czakai,; Ralf Claus,; Jürgen Löffler,; Hortense Slevogt and; Rainer KönigEmail author. BMC Genomics :601. https://doi.org s x. © The Author(s) Received:

Lars Kaiser, Helga Weinschrott, Isabel Quint, Folker Wenzel, Markus Blaess, Manfred Jung, Matthias Kohl, Hans-Peter Deigner Int J Mol Sci.

5 Allgemeine Veröffentlichungen

von K Wolff · · Zitiert von: 24 — ... a clash of an altered sphingolipid-metabolism and lysosomotropism of drugs accumulating in the skin? 08 November Markus Blaess, Lars Kaiser, …

von JP Saraiva · · Zitiert von: 1 — João Pedro Saraiva, Marcus Oswald, Antje Biering, Daniela Röll, Markus Blaess, Ralf Claus & Rainer König. von U Runne · — ... a clash of an altered sphingolipid-metabolism and lysosomotropism of drugs accumulating in the skin? 08 November Markus Blaess, Lars Kaiser, …

Markus Blaess, Oliver Sommerfeld, René Csuk, Hans-Peter Deigner , Exploration of Immunology · Sepsis biomarkers and diagnostic tools with a focus on ...

von O Braun-Falco · — ... a clash of an altered sphingolipid-metabolism and lysosomotropism of drugs accumulating in the skin? 08 November Markus Blaess, Lars Kaiser, …

1 Meinungen & Artikel

von D Medeiros · — Markus Blaess et al.Editorial: Drug repurposing and polypharmacology: A synergistic approach in multi-target based drug discovery.

35 Webfunde aus dem Netz

11. Aug · COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks. International Journal of Molecular Sciences | Journal article. DOI: ijms Contributors : Markus Blaess; Lars Kaiser; Martin Sauer; René Csuk; Hans-Peter Deigner.

— ... blisters – is AGEP a clash of an altered sphingolipid-metabolism and lysosomotropism of drugs accumulating in the skin? by Markus Blaess. › drug-trigger...

Results of 17 — Markus Blaess et al. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences... Results of 33 — Markus Blaess et al. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences...

Markus Blaess Röll Cora Assmann Tilman Klassert Markus Blaess Kristin Czakai Ralf Claus Jürgen Löffler Hortense Slevogt Rainer König.

Markus Blaess. Lars Kaiser. Oliver Sommerfeld. René Csuk. Hans-Peter Deigner. With settings. Email: Freq: Daily, Weekly, Monthly ... Markus Blaess. Lars Kaiser. Martin Sauer. René Csuk. Hans-Peter Deigner. With settings. Email: Freq: Daily, Weekly, Monthly ...

Markus Blaess, Lars Kaiser, Martin Sauer, René Csuk, Hans-Peter Deigner International Journal of Molecular Sciences July 13, 21 (14). › read › cov...

Markus Blaess et al., Lipids in Health and Disease, Early intervention of atopic dermatitis as a preventive strategy for progression of food allergy.

British Journal of Medicine & Medical Research 2015, 8 (6): ISSN , DOI: / BJMMR Markus Blaess, H.P. Le, Ralf A. Claus, Matthias Kohl, ...

Too many files! · S. Lambeck · Daniel Rittirsch · Sandro Lindig · Veit Schoenborn · Markus Blaess · Paolo Cinelli · Michael Bauer · Ralf Claus.

Markus Blaess et al. Frontiers in Pharmacology, On the Management of Drug Interactions in the Course of Concomitant Treatments for COVID-19 and ...

Markus Blaess et al., Lipids in Health and Disease, Powered by · Targeting settings · Do not sell my personal information · Google Analytics settings.

... Ceramide Metabolism in Atopic Dermatitis (AD): A Causal Starting Point for a Personalized (Basic) Therapy. by Markus Blaess 1 and Hans-Peter Deigner 1,2,*.

von NL Marsh · · Zitiert von: 84 — Markus Blaess et al., Lipids in Health and Disease, Blood–brain barrier dysfunction in l-ornithine induced acute pancreatitis in rats and the direct ...

von L Kaiser · · Zitiert von: 3 — Lars Kaiser,1,2 Helga Weinschrott,1 Isabel Quint,1Markus Blaess,1 René Csuk,3 Manfred Jung,2,4 Matthias Kohl,1 and Hans-Peter Deigner1,5,6,* ...

von M Blaess · · Zitiert von: 7 — Author: Markus Blaess, Ralf A. Claus, Hans-Peter Deigner; Source: Journal of Chromatography B v pp ; ISSN:

Lars Kaiser, Helga Weinschrott, Isabel Quint, Folker Wenzel, Markus Blaess, Manfred Jung, Matthias Kohl, Hans-Peter Deigner.

Lysosomotropism is a biological characteristic of small molecules, independently present of their intrinsic pharmacological effects. Lysosomotropic compounds,...

von L Kaiser · · Zitiert von: 3 — Helga Weinschrott 1, Isabel Quint 1, Markus Blaess 1. , René Csuk 3. ,. Manfred Jung 2,4. , Matthias Kohl 1 and Hans-Peter Deigner 1,5,6,*.

Markus Blaess 1 ,. Affiliation: 2Department of Anaesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.

von M Blaess · · Zitiert von: 3 — Markus Blaess1, www.frontiersin.org Lars Kaiser1,2, www.frontiersin.org Oliver Sommerfeld3, www.frontiersin.org ... Markus Blaess. Friedrich Schiller University Jena. Jena, Germany. View All. mini profile avatar Markus Blaess. Overview · Bio · Network11 · Publications ... › full › people